Clinical Profile of Methotrexate-resistant Juvenile Localised Scleroderma
Methotrexate has demonstrated its efficiency for the treatment of juvenile localized scleroderma but some patients may be resistant. The aim of our study was to define the profile of such patients.
Juliette Hardy +19 more
doaj +2 more sources
Sarcopenia in juvenile localized scleroderma: new insights on deep involvement
Juvenile localized scleroderma (JLS) is a rare chronic autoimmune disease which can also affect bones and muscles. Nevertheless, muscle loss was not previously investigated in patients with JLS. Thus, the aim of this study was to retrospectively evaluate deep involvement and assess and quantify sarcopenia in JLS patients using magnetic resonance ...
Silvia Karem Janet Flores Quispe +7 more
openaire +3 more sources
A Rare Case of Juvenile Systemic Sclerosis: Clinical Challenges and Management
Scleroderma is “skleros” sclerosing or hardening of the “derma” skin. It includes both systemic and localized scleroderma (LS). Mostly, juvenile LS affects the skin, whereas juvenile systemic sclerosis (SSc) involves multiple organ systems.
Areej Bano +2 more
doaj +2 more sources
Durometry as an outcome measure in juvenile localized scleroderma. [PDF]
Poff S +4 more
europepmc +4 more sources
Esophageal involvement in juvenile localized scleroderma: a pilot study.
To evaluate the esophageal involvement in patients with juvenile localized scleroderma (JLS).A cohort of patients with JLS underwent esophageal stationary manometry to evaluate esophageal motility and lower esophageal sphincter (LES) function, distal esophagus 24-hour pH-monitoring to detect gastroesophageal reflux (GER) and upper gastrointestinal (GI)
Guariso G. +5 more
openaire +4 more sources
Long-term methotrexate efficacy in juvenile localized scleroderma [PDF]
Giuliotto S +5 more
doaj +2 more sources
Reliability of using an ultrasound scoring measure for juvenile localized scleroderma (jLS) [PDF]
Li Suzanne C +13 more
doaj +2 more sources
Calcinosis Cutis and Delayed-Onset Myositis in a Case of Suspected Localized Scleroderma: A Diagnostic and Therapeutic Challenge. [PDF]
ABSTRACT A 16‐year‐old girl presenting with calcinosis cutis and localized scleroderma subsequently developed delayed‐onset idiopathic inflammatory myopathy five years after initial skin involvement. Despite the absence of typical dermatomyositis features and negative myositis‐specific antibodies, whole‐body MRI revealed extensive subclinical muscle ...
Marrani E +5 more
europepmc +2 more sources
Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. [PDF]
AbstractObjectiveJuvenile localized scleroderma (LS) is a chronic inflammatory skin disorder associated with substantial morbidity and disability. Although a wide range of therapeutic strategies has been reported in the literature, a lack of agreement on treatment specifics and accepted methods for clinical assessment has made it difficult to compare ...
Li SC +24 more
europepmc +4 more sources
Nailfold capillary phenotypes distinguish juvenile myositis subtypes and associate with disease activity. [PDF]
Nailfold capillaroscopy is a non‐invasive imaging tool that can aid in the diagnosis and monitoring of juvenile myositis. Branched nailfold capillary morphology is more common in juvenile myositis patients, particularly those positive for TIF1γ+ autoantibodies. Juvenile myositis patients with more active disease demonstrate increased microhaemorrhages,
McClellan N +7 more
europepmc +2 more sources

